Shanghai Haohai Biological Technology Co Ltd (6826)

Hong Kong
Currency in HKD
27.20
+0.05(+0.18%)
Closed
6826 Scorecard
Full Analysis
Management has been aggressively buying back shares
High dividend Yield
Fair Value
Day's Range
26.9527.70
52 wk Range
23.5542.95
Key Statistics
Edit
Bid/Ask
27.20 / 27.20
Prev. Close
27.2
Open
27.15
Day's Range
26.95-27.7
52 wk Range
23.55-42.95
Volume
237.9K
Average Volume (3m)
476.29K
1-Year Change
-5.33%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6826 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
42.51
Upside
+56.27%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Shanghai Haohai Biological Technology Co Ltd Company Profile

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. The company offers ophthalmology products consisting intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. It also offers sodium hyaluronate injection, medical chitosan, sodium hyaluronate gel, sodium hyaluronate gel, anti adhesion, and burn wound related products. In addition, the company provides injectors, scalpels, and suture needles. Further, it offers medical aesthetics products comprising Matrifill, a first-generation hyaluronic acid (HA) dermal filler, which is a mono-phase sodium hyaluronate gel for injection; Janlane, a second-generation HA dermal filler for dynamic filling function; Hyalumatrix, a third-generation HA dermal filler that offers precise embellishment function; genetic-engineering preparations for epidermal repair; and radio frequency devices and laser equipment. Additionally, the company is involved in the research and development of biological engineering and pharmaceutical products, as well as in the provision of related technology transfer, and consultation services; sale of professional life and home cosmetology machines; and manufacture and sale of biological reagents, biologicals and biological materials, and other machines and accessories. The company was formerly known as Haohai Limited and changed its name to Shanghai Haohai Biological Technology Co., Ltd. in 2010. Shanghai Haohai Biological Technology Co., Ltd. was founded in 2007 and is headquartered in Shanghai, China.

Compare 6826 to Peers and Sector

Metrics to compare
6826
Peers
Sector
Relationship
P/E Ratio
29.7x−1.0x−0.5x
PEG Ratio
9.040.330.00
Price/Book
2.2x3.7x2.6x
Price / LTM Sales
4.6x11.3x3.0x
Upside (Analyst Target)
56.1%29.1%55.6%
Fair Value Upside
Unlock−6.0%10.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 42.51
(+56.27% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.29%
Dividend Yield
5.66%
Industry Median 0.79%
Annualised payout
1.5369
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 18, 2025
EPS / Forecast
-- / --
Revenue / Forecast
623.00M / --
EPS Revisions
Last 90 days

FAQ

What Is the Shanghai Haohai Biological Tech (6826) Stock Price Today?

The Shanghai Haohai Biological Tech stock price today is 27.20

What Stock Exchange Does Shanghai Haohai Biological Tech Trade On?

Shanghai Haohai Biological Tech is listed and trades on the Hong Kong stock exchange.

What Is the Stock Symbol for Shanghai Haohai Biological Tech?

The stock symbol for Shanghai Haohai Biological Tech is "6826."

Does Shanghai Haohai Biological Tech Pay Dividends? What’s The Current Dividend Yield?

The Shanghai Haohai Biological Technology Co Ltd dividend yield is 4.50%.

What Is the Shanghai Haohai Biological Tech Market Cap?

As of today, Shanghai Haohai Biological Tech market cap is 13.27B.

What is Shanghai Haohai Biological Tech Earnings Per Share?

The Shanghai Haohai Biological Tech EPS is 1.29.

What Is the Next Shanghai Haohai Biological Tech Earnings Date?

Shanghai Haohai Biological Tech will release its next earnings report on 29 Apr 2025.

From a Technical Analysis Perspective, Is 6826 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.